Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 83 results for "mylan"

USFDA issues warning letter to Mylan for Nashik facility
Money Control

USFDA issues warning letter to Mylan for Nashik facility

The US health regulator has issued a warning letter to drug firm Mylan for violations of good manufacturing norms, including data integrity lapses and failure of quality control at its Nashik facility. DNA, 1 week ago

748 images for mylan

Money Control, 1 week ago
Reuters, 1 day ago
Reuters, 3 weeks ago
Reuters, 1 week ago
First Post.com, 1 week ago
Reuters, 3 weeks ago
Reuters, 4 weeks ago
Reuters, 3 weeks ago
Money Control, 1 month ago
The Telegraph UK, 1 month ago
Business Standard

Mylan inks settlement pact with Genentech & Roche on cancer drug Herceptin

Trastuzumab (Herceptin) is one of the 6 biologic products co-developed by Mylan & Biocon BS B2B Bureau | Pittsburgh, USA March 14, 2017 Last Updated at 16:28 IST Mylan NV has agreed to the terms of a global settlement with Genentech Inc and F. Hoffmann-La ...
 Business Standard1 month ago Biocon and Mylan get USFDA approval to jointly develop biologic product  First Post.com2 months ago US FDA accepts application of Mylan & Biocon for biosimilar pegfilgrastim  Business Standard2 months ago FDA accepts Mylan's BLA for proposed biosimilar Pegfilgrastim  DNA2 months ago
Money Control

Biocon, Alkem Labs surge on US FDA nods to products

Biocon surged after Mylan got a nod for breast cancer tablets, while Alkem Labs rose due to a nod for an ointment to treat ventricular tachycardia.
 Money Control1 month ago According to Biocon and Mylan, their respective breast  DNA2 months ago Can Biocon, Mylan drugs be used for early breast cancer: HC  DNA2 months ago

Delhi HC rejects Sun Pharma appeal in Oxaliplatin case against Mylan Labs

Despite noting importance of first syllable of trade name, HC didn't find 'Ox' and 'Sox' similar
 Business Standard1 month ago HC dismisses Sun Pharma's plea against Mylan on Oxaliplatin trademark case  Business Standard2 months ago

HC allows Biocon, Mylan to sell their drug for three cancers

The Delhi High Court today allowed drug companies Biocon and Mylan to sell their version of Trastuzumab for two kinds of breast cancer and metastatic gastric cancer in view of the approval granted to it by the Drugs Controller General of India (DCGI).
 DNA1 month ago Setback for Roche: Mylan, Biocon can now sell generics of its cancer drug  Business Standard1 month ago
Money Control

Analysts cheer Mylan-Roche settlement, upbeat on Biocon

Feel better product launch visibility and first movers advantage to aid its financials; largely maintain buy call on the stock
 Money Control1 month ago

Mylan deal removes uncertainty over launch of Trastuzumab biosimilar: Biocon Chief

Global healthcare company Mylan has inked a settlement pack with Genentech and Roche in relation to patents for cancer drug Herceptin (Trastuzumab).
 Money Control1 month ago

Mylan deal clears path for biosimilar copy of Roche's Herceptin

LONDON (Reuters) - Generic drugmaker Mylan said on Monday it had reached a settlement with Roche providing "a clear pathway" for the launch of its biosimilar version of the Swiss company's top-selling breast cancer drug Herceptin in major markets.
 Business Standard1 month ago

Biocon chief sees anti-cancer biosimilar launch in FY19

Biocon Thursday announced the US Food and Drug Administration has accepted Mylan’s Biologics License Application (BLA) for biosimilar chemotherapy drug Pegfilgrastim for review. Sharing details on the development with CNBC-TV18 Biocon Chairperson and ...
 Money Control2 months ago USFDA accepts Mylan's application for proposed biosimilar  Business Standard2 months ago
Business Line

Federal appeals court rules Mylan can proceed with generic Angiomax

A U.S. appeals court ruled that Mylan Inc's proposed generic version of the blood thinner Angiomax would not infringe on patents held by The Medicines Company. The U.S. Court of Appeals for the Federal Circuit reversed a decision by a federal judge in ...
 Reuters2 weeks ago Natco gets a booster dose on favorable patent ruling in US  Money Control2 months ago Natco Pharma climbs after partner wins patent case in US  DNA2 months ago US Court rules in favour of Mylan for Copaxone patents: Natco  DNA2 months ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less